Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLXN

Silexion Therapeutics Corp

May 29 • 04:00PM ET

4.91

+0.63 14.82 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-59.70	Insider Own	8.10%	Shs Outstand	0.42M	Perf Week	3.36%
Market Cap	2.09M	Forward P/E	-	EPS next Y	-28.65	Insider Trans	-43.36%	Shs Float	0.39M	Perf Month	-22.19%
Enterprise Value	1.69M	PEG	-	EPS next Q	-13.10	Inst Own	91.90%	Short Float	4.13%	Perf Quarter	-71.54%
Income	-12.90M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.03	Perf Half Y	-79.54%
Sales	-	P/B	5.71	EPS next Y	-	ROA	-345.90%	Short Interest	0.02M	Perf YTD	-74.43%
Book/sh	0.86	P/C	0.87	EPS next 5Y	-	ROE	698.20%	52W High	223.60 -97.80%	Perf Year	-96.59%
Cash/sh	5.64	P/FCF	-	EPS past 3/5Y	- -	ROIC	-250.80%	52W Low	2.31 112.53%	Perf 3Y	-99.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	17.32% 19.21%	Perf 5Y	-99.96%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	96.81%	Oper. Margin	-	ATR (14)	1.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.06	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	94.80%	SMA20	1.38%	Beta	-0.35	Target Price	60.00
Payout	-	Debt/Eq	6.67	Sales Q/Q	-	SMA50	-41.29%	Rel Volume	0.54	Prev Close	4.28
Employees	13	LT Debt/Eq	1.00	Earnings	May 18 BMO	SMA200	-81.15%	Avg Volume	570.46K	Price	4.91
IPO	Apr 07, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	34.11% -	Trades		Volume	308,458	Change	14.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)